Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary HIV-1 infection in users of pre-exposure prophylaxis.
Ambrosioni J, Petit E, Liegeon G, Laguno M, Miró JM. Ambrosioni J, et al. Among authors: laguno m. Lancet HIV. 2021 Mar;8(3):e166-e174. doi: 10.1016/S2352-3018(20)30271-X. Epub 2020 Dec 11. Lancet HIV. 2021. PMID: 33316212 Review.
[GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)].
Miró JM, Torre-Cisnero J, Moreno A, Tuset M, Quereda C, Laguno M, Vidal E, Rivero A, Gonzalez J, Lumbreras C, Iribarren JA, Fortún J, Rimola A, Rafecas A, Barril G, Crespo M, Colom J, Vilardell J, Salvador JA, Polo R, Garrido G, Chamorro L, Miranda B. Miró JM, et al. Among authors: laguno m. Enferm Infecc Microbiol Clin. 2005 Jun-Jul;23(6):353-62. doi: 10.1157/13076175. Enferm Infecc Microbiol Clin. 2005. PMID: 15970168 Review. Spanish.
Liver transplantation in HIV/hepatitis co-infection.
Miro JM, Aguero F, Laguno M, Tuset M, Cervera C, Moreno A, Garcia-Valdecasas JC, Rimola A; Hospital Clinic OLT in HIV Working Group. Miro JM, et al. Among authors: laguno m. J HIV Ther. 2007 Mar;12(1):24-35. J HIV Ther. 2007. PMID: 17589393 Review.
Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
Larrousse M, Laguno M, Segarra M, De Lazzari E, Martinez E, Blanco JL, León A, Deulofeu R, Miquel R, Milinkovic A, Lonca M, Miró JM, Biglia A, Murillas J, Gatell JM, Mallolas J. Larrousse M, et al. Among authors: laguno m. J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):304-11. doi: 10.1097/qai.0b013e3181520502. J Acquir Immune Defic Syndr. 2007. PMID: 18172937
Management of end-stage liver disease in HIV-infected patients.
Agüero F, Laguno M, Moreno A, Rimola A, Miró JM; Hospital Clinic OLT in HIV Working Group. Agüero F, et al. Among authors: laguno m. Curr Opin HIV AIDS. 2007 Nov;2(6):474-81. doi: 10.1097/COH.0b013e3282f0aadd. Curr Opin HIV AIDS. 2007. PMID: 19372930
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.
Martínez E, Arranz JA, Podzamczer D, Loncá M, Sanz J, Barragán P, Ribera E, Knobel H, Roca V, Gutiérrez F, Blanco JL, Mallolas J, Llibre JM, Clotet B, Dalmau D, Segura F, Arribas JR, Cosín J, Barrufet P, Casas E, Ferrer E, Curran A, González A, Pich J, Cruceta A, Arnaiz JA, Miró JM, Gatell JM; BICOMBO Study Team. Martínez E, et al. J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):290-7. doi: 10.1097/QAI.0b013e3181aa12d5. J Acquir Immune Defic Syndr. 2009. PMID: 19398921 Clinical Trial.
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators. Murillas J, et al. Among authors: laguno m. Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735. Liver Transpl. 2009. PMID: 19718643 Free article.
154 results